Error message

The page you requested does not exist. For your convenience, a search was performed using the query Surgical Oncology.

Page not found

Search results

  1. From Chemical to Drug: The Path to a Small Molecule IND

    Oncology lead for ibrutinib, a first-in-class BTK inhibitor jointly developed and marketed ... metabolic diseases, neuroscience, immunology, neuroscience and oncology. In addition to Silvia’s Regulatory ... immunology, neuroscience and oncology. Additionally, she has lead staff supporting toxicology and DMPK project ...

  2. From Chemical to Drug- The Path to a Small Molecule IND

    to clinical development to become the ClinPharm Oncology lead for ibrutinib, a first-in-class BTK inhibitor ... and oncology. In addition to Silvia's Regulatory experience, she has worked in Quality Assurance. ... and cardiovascular diseases, immunology, neuroscience and oncology. Additionally, she has lead staff supporting ...

  3. [NYC session] From Chemical to Drug- The Path to a Small Molecule IND

    in the Cardiovascular and Metabolism, Immunology, Neuroscience, and Oncology therapeutic areas. In addition to using ... of this role, he is responsible for a portfolio of discovery and development projects in the Oncology ... to facilitate clinical drug development and approval in cardiovascular, metabolic, immunology, and oncology ...

  4. [San Antonio TX session] Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

    through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His ...

  5. The Doctor Will "Tweet" You Now

    in audience-based, agile analytics. Meredith’s client work includes Takeda Oncology, Amgen, Sanofi Diabetes, UCB, ...

  6. Spotlight on JLABS | May 2015

    Leadership: Stephanie Hsieh, President, CEO Focus: Oncology therapeutics Meditope’s novel platform technology ...

  7. ABCs of the FDA – How to… Set a Preclinical Roadmap

    he is responsible for a portfolio of discovery and development projects in the Oncology ...

  8. Spotlight on JLABS | September 2015

    Sowadski, Co-Founder, CSO Focus: Oncology Diagnostics DNA SEQ's primary technology platform ...

  9. JLABS Innovator Spotlight and Mixer- November 2015

    Inc. Leadership: Kenneth Lin, CEO Commencement date: 04/01/2015 Focus: Oncology At Ab Initio, we ...

  10. ABCs of the FDA – How to… Set a Preclinical Roadmap [At the door]

    and development projects in the Oncology, Cardiovascular and Metabolism therapeutic areas. Mike is also ...

Pages

Share